// App-Quantinova.ai

: Effects of plasma kallikrein inhibitors in an in vitro RPE oxidative stress model

Researchers

Presenter

  • M.L. Alonso-Alonso

Principal Investigators

  • S.L. Hampton

  • J.L. Williams

  • M.T. Garca-Gutirrez

  • I. Fernndez-Bueno

  • G.K. Srivastava

  • J.C. Pastor

  • Y. Diebold

Medical Centers

  • Institute of Applied Ophthalmo‐Biology IOBA, University of Valladolid, Valladolid, Spain

  • KalVista Pharmaceuticals, Ltd., Porton Down‐ Salisbury, UK

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • benzalkonium chloride solution

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved